About this information
Search the summaries of completed Access to Information (ATI) requests to find information about ATI requests made to the Government of Canada after January 2020. If you find a summary of interest, you can request a copy of the records at no cost using the form below each summary. Requests made through this form are considered informal requests and are not subject to the same requirements as requests under the Access to Information Act (ATIA).
If you don’t find what you are looking for you can request additional government records under an institution’s control by contacting the institution’s Access to Information and Privacy Coordinator or by submitting a formal access to information request.
*All information provided will incorporate the necessary exemptions and exclusions as per the Access to Information Act and the Privacy Act.
Download datasets of the summaries of completed access to information requests.
Current Search
Report Type
Organization
Disposition
Year
Month
Found 6696 record(s)
Req # A-2020-001221
All documents regarding the acquisition of ventilators and any documents showing their current status from March 1, 2020 to November 25, 2020.Organization: Health Canada
January 2025
Req # A-2021-000042
All communications sent/rec’d by officials at the Director General (DG), Assisstant Deputy Minister (ADM) or Deputy Minister (DM) level regarding or discussing Spartan Bioscience/it’s government contracts/it’s bankruptcy. Limit timeframe to January…Organization: Health Canada
January 2025
Req # A-2021-000166
All email communications between Health Canada media relations and communications staff and Switch health. Time Period: January 15, 2021 to May 7, 2021.Organization: Health Canada
January 2025
Req # A-2021-001459
All correspondence and documents related to the award of contract with Ipsos-Reid Corporation (Procurement Identification Number: HT37213292 ) referred to in this proactive disclosure report:https://search.open.canada.ca/en/ct/id/hc-sc,C-2021-2022-…Organization: Health Canada
January 2025
Req # A-2021-001973
The Screening acceptance letter(s) sent from Health Canada to any and all generic drug manufacturer(s) for any and all Abbreviated New Drug Submission(s) (ANDS) for the medicinal ingredient risperidone which appear(s) on the list of Generic Drug…Organization: Health Canada
January 2025
Req # A-2021-001988
All training / guidance materials, memos, and policy documents utilized by Health Canada when reviewing a Notice of New Cannabis Product submission received under the Cannabis Act. All training / guidance materials, memos, and policy documents…Organization: Health Canada
January 2025
Req # A-2023-000160
The safety summary reports of the hematological monitoring for AA-Clozapine-associated neutropenia/agranulocytosis. Date ranges: All available reports. Manufacturer: AA Pharma Inc. The request references all marketed strengths of AA-Clozapine…Organization: Health Canada
January 2025
Req # A-2023-000440
In response to OPQ #1448, Health Canada responded as follows: "The referred report [5.3.6 CUMULATIVE ANALYSIS OF POST-AUTHORIZATION ADVERSE EVENT REPORTS OF PF-07302048 (BNT162B2) RECEIVED THROUGH 28-FEB-2021. During the time period referenced…Organization: Health Canada
January 2025
Req # A-2023-000818
All correspondence between Pest Management Regulatory Agency (PMRA) staff, Corteva (formerly Dow Agroscience) and the Ethylene Bisdithiocarbamate/Ethylene Thiourea (EBDC/ETU) task force regarding mancozeb drinking water monitoring and estimated…Organization: Health Canada
January 2025
Req # A-2023-000932
Information on the review status of the Abbreviated New Drug Submission (ANDS) for liraglutide accepted into review in August 2017, including but not limited to a screen shot from Health Canada’s Drug Submission Tracking System (DSTS) for this ANDS.Organization: Health Canada
January 2025